• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

升高的C反应蛋白作为姑息性手术后患者预后的预测指标。

Elevated C-reactive protein as a predictor of patient outcomes following palliative surgery.

作者信息

Blakely Andrew M, Heffernan Daithi S, McPhillips Jane, Cioffi William G, Miner Thomas J

机构信息

Department of Surgery, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

出版信息

J Surg Oncol. 2014 Nov;110(6):651-5. doi: 10.1002/jso.23682. Epub 2014 Jun 25.

DOI:10.1002/jso.23682
PMID:24964899
Abstract

BACKGROUND AND OBJECTIVES

Optimal surgical decision-making and informed consent for palliative procedures is limited by a lack of appropriate outcomes data. Elevated C-reactive protein (CRP) may help guide patient selection for palliative surgery.

METHODS

Procedures to palliate symptoms of advanced cancer were identified from a prospective palliative surgery database. Patients with a recorded preoperative serum CRP were identified and observed for at least 180 days or until death.

RESULTS

Fifty patients were identified who underwent an elective palliative procedure from July 2006 to June 2012. Presenting symptoms included gastrointestinal obstruction (40%), tumor-related pain (38%) or bleeding (12%), and other (10%). Symptom improvement was documented for 37 patients (74%). Palliative procedures were associated with 30-day postoperative morbidity (42%) and mortality (10%). CRP (range 1-144 mg/L, median 9.7 mg/L) was elevated in 27 patients (54%) and was independently associated with developing a major complication (P = 0.005) and decreased overall survival (166 vs. 659 days, P < 0.0001).

CONCLUSIONS

Patients with advanced cancer can be afforded symptom improvement and the opportunity for improved quality of life following palliative procedures. Elevated preoperative CRP may help identify patients who are less likely to realize the benefits of palliative operations.

摘要

背景与目的

由于缺乏合适的预后数据,姑息治疗手术的最佳决策制定及知情同意受到限制。C反应蛋白(CRP)升高可能有助于指导姑息性手术的患者选择。

方法

从一个前瞻性姑息性手术数据库中识别出缓解晚期癌症症状的手术。识别出术前血清CRP有记录的患者,并对其进行至少180天的观察或直至死亡。

结果

确定了50例在2006年7月至2012年6月期间接受择期姑息性手术的患者。主要症状包括胃肠道梗阻(40%)、肿瘤相关疼痛(38%)或出血(12%)以及其他(10%)。记录到37例患者(74%)症状改善。姑息性手术与术后30天发病率(42%)和死亡率(10%)相关。27例患者(54%)CRP升高(范围1 - 144mg/L,中位数9.7mg/L),且与发生严重并发症独立相关(P = 0.005)以及总体生存期缩短相关(166天对659天,P < 0.0001)。

结论

晚期癌症患者在接受姑息性手术后症状可得到改善,生活质量有提高的机会。术前CRP升高可能有助于识别不太可能从姑息性手术中获益的患者。

相似文献

1
Elevated C-reactive protein as a predictor of patient outcomes following palliative surgery.升高的C反应蛋白作为姑息性手术后患者预后的预测指标。
J Surg Oncol. 2014 Nov;110(6):651-5. doi: 10.1002/jso.23682. Epub 2014 Jun 25.
2
The palliative triangle: improved patient selection and outcomes associated with palliative operations.姑息治疗三角:改善姑息手术的患者选择及预后
Arch Surg. 2011 May;146(5):517-22. doi: 10.1001/archsurg.2011.92.
3
A prospective, symptom related, outcomes analysis of 1022 palliative procedures for advanced cancer.一项针对1022例晚期癌症姑息治疗手术的前瞻性、症状相关结局分析。
Ann Surg. 2004 Oct;240(4):719-26; discussion 726-7. doi: 10.1097/01.sla.0000141707.09312.dd.
4
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.复发性卵巢癌所致恶性肠梗阻姑息治疗手术的前瞻性疗效分析
Oncologist. 2009 Aug;14(8):835-9. doi: 10.1634/theoncologist.2009-0057. Epub 2009 Aug 14.
5
The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.C反应蛋白水平升高和低白蛋白血症对接受姑息治疗的晚期不可切除食管癌患者生存的影响。
J Surg Oncol. 2014 Nov;110(6):645-50. doi: 10.1002/jso.23711. Epub 2014 Jun 29.
6
Surgical palliation for malignant disease requiring locoregional control.针对需要局部区域控制的恶性疾病的手术姑息治疗。
Ann Palliat Med. 2015 Apr;4(2):48-53. doi: 10.3978/j.issn.2224-5820.2015.04.03.
7
C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.C 反应蛋白:根治性肾输尿管切除术治疗局限性上尿路上皮癌患者生存的生物标志物。
Urol Oncol. 2013 Nov;31(8):1725-30. doi: 10.1016/j.urolonc.2012.05.008. Epub 2012 Nov 8.
8
Can patient reported outcomes help identify the optimal outcome in palliative surgery?患者报告结局能否有助于确定姑息手术的最佳结局?
J Surg Oncol. 2014 Feb;109(2):145-50. doi: 10.1002/jso.23466. Epub 2013 Oct 16.
9
Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention.复发性妇科恶性肿瘤中的肠梗阻:明确谁将受益于手术干预。
Eur J Surg Oncol. 2014 Jul;40(7):899-904. doi: 10.1016/j.ejso.2013.10.025. Epub 2013 Nov 13.
10
Indicators of symptom improvement and survival in inpatients with advanced cancer undergoing palliative surgical consultation.晚期癌症住院患者接受姑息性外科咨询后的症状改善和生存指标。
J Surg Oncol. 2013 Mar;107(4):367-71. doi: 10.1002/jso.23236. Epub 2012 Aug 6.

引用本文的文献

1
Definition of Palliative Surgery in Cancer Care: A Systematic Review.癌症护理中姑息性手术的定义:一项系统综述
J Surg Oncol. 2024 Nov 28. doi: 10.1002/jso.28016.
2
A systematic review of the overlap of fluid biomarkers in delirium and advanced cancer-related syndromes.一项关于谵妄和晚期癌症相关综合征中液体生物标志物重叠的系统评价。
BMC Psychiatry. 2020 Apr 22;20(1):182. doi: 10.1186/s12888-020-02584-2.
3
Inflammation and pro-resolution inflammation after hepatobiliary surgery.肝胆手术后的炎症和促解决炎症。
World J Surg Oncol. 2017 Aug 10;15(1):152. doi: 10.1186/s12957-017-1220-6.
4
Serum C-reactive protein and overall survival of patients with osteosarcoma.骨肉瘤患者的血清C反应蛋白与总生存期
Tumour Biol. 2015 Jul;36(7):5663-6. doi: 10.1007/s13277-015-3240-6. Epub 2015 May 19.